Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Madrigal Pharmaceuticals Inc.
Sponsor

Madrigal Pharmaceuticals Inc.

United States 200 Barr Harbor Drive Suite 400, 19428-2978, United States

About the sponsor

Madrigal Pharmaceuticals Inc. focuses on clinical research in NASH, with trials centered on disease activity, histological improvement, and prevention of progression in adults with fatty liver-related inflammation and fibrosis.

  • Non-Alcoholic Steatohepatitis
  • NAFLD activity score
  • Fibrosis
  • Liver biopsy

The sponsor’s studies examine liver tissue changes associated with NASH, including resolution of inflammatory features and improvement in scarring.

About Specializations

Madrigal Pharmaceuticals Inc. runs clinical trials in conditions such as Metabolic dysfunction-associated steatohepatitis, Non-alcoholic steatohepatitis, Hepatic cirrhosis, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Resmetirom
  • Sponsor:Madrigal Pharmaceuticals Inc.

Hepatic cirrhosis

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Resmetirom
  • Sponsor:Madrigal Pharmaceuticals Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.